Miriam Anne Murphy, the President of $SNX, sold 100 shares of the company on 10-31-2025 for an estimated $15,652. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.6% of their shares of this class of stock. Following this trade, they now own 16,529 shares of this class of $SNX stock.
$SNX Insider Trading Activity
$SNX insiders have traded $SNX stock on the open market 48 times in the past 6 months. Of those trades, 0 have been purchases and 48 have been sales.
Here’s a breakdown of recent trading of $SNX stock by insiders over the last 6 months:
- RICHARD T HUME has made 0 purchases and 8 sales selling 68,310 shares for an estimated $9,403,971.
 - DENNIS POLK (Hyve Solutions Executive) has made 0 purchases and 23 sales selling 49,750 shares for an estimated $7,164,099.
 - MARSHALL WITT (Chief Financial Officer) has made 0 purchases and 6 sales selling 4,093 shares for an estimated $571,345.
 - ALIM DHANJI (Chief Human Resources Officer) has made 0 purchases and 7 sales selling 3,019 shares for an estimated $451,331.
 - MIRIAM ANNE MURPHY (President, Europe) has made 0 purchases and 2 sales selling 1,673 shares for an estimated $261,810.
 - ANN F VEZINA sold 812 shares for an estimated $122,141
 - REYNA THOMPSON (President, North America) sold 521 shares for an estimated $81,265
 
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SNX Hedge Fund Activity
We have seen 217 institutional investors add shares of $SNX stock to their portfolio, and 274 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NINETY ONE UK LTD removed 979,248 shares (-33.2%) from their portfolio in Q3 2025, for an estimated $160,351,860
 - VANGUARD GROUP INC added 759,022 shares (+10.1%) to their portfolio in Q2 2025, for an estimated $102,999,285
 - AQR CAPITAL MANAGEMENT LLC removed 618,227 shares (-63.2%) from their portfolio in Q2 2025, for an estimated $83,893,403
 - THRIVENT FINANCIAL FOR LUTHERANS removed 572,729 shares (-94.9%) from their portfolio in Q2 2025, for an estimated $77,719,325
 - DIMENSIONAL FUND ADVISORS LP added 525,027 shares (+23.5%) to their portfolio in Q2 2025, for an estimated $71,246,163
 - JONES FINANCIAL COMPANIES LLLP removed 498,926 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $67,704,258
 - CITADEL ADVISORS LLC added 453,155 shares (+90.6%) to their portfolio in Q2 2025, for an estimated $61,493,133
 
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SNX Analyst Ratings
Wall Street analysts have issued reports on $SNX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 09/29/2025
 - Barrington Research issued a "Outperform" rating on 09/29/2025
 - RBC Capital issued a "Outperform" rating on 09/26/2025
 - Morgan Stanley issued a "Overweight" rating on 09/26/2025
 - B of A Securities issued a "Buy" rating on 09/26/2025
 - Loop Capital issued a "Buy" rating on 06/30/2025
 
To track analyst ratings and price targets for $SNX, check out Quiver Quantitative's $SNX forecast page.
$SNX Price Targets
Multiple analysts have issued price targets for $SNX recently. We have seen 9 analysts offer price targets for $SNX in the last 6 months, with a median target of $180.0.
Here are some recent targets:
- Vincent Colicchio from Barrington Research set a target price of $182.0 on 09/29/2025
 - David Vogt from UBS set a target price of $187.0 on 09/29/2025
 - Ruplu Bhattacharya from B of A Securities set a target price of $180.0 on 09/26/2025
 - Tim Long from Barclays set a target price of $164.0 on 09/26/2025
 - Erik Woodring from Morgan Stanley set a target price of $181.0 on 09/26/2025
 - Michael Ng from Goldman Sachs set a target price of $164.0 on 09/26/2025
 - Ashish Sabadra from RBC Capital set a target price of $180.0 on 09/26/2025
 
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.